Comparative safety of the different macrolides

Area of Science:

• Pharmacology
• Infectious Diseases
• Drug Interactions

Background:

• Macrolide antibiotics are frequently prescribed for acute infections and prophylaxis due to good tolerability.
• Potential side effects, though rare, include QT(c) prolongation with certain macrolides.
• Metabolism via P450 isoenzymes raises concerns for drug-drug interactions.

Purpose of the Study:

• To review the safety profile of macrolide antibiotics.
• To identify potential drug interactions associated with macrolide use.
• To compare the interaction potential of different macrolides, particularly azithromycin versus erythromycin and clarithromycin.

Main Methods:

• Review of existing literature on macrolide antibiotic tolerability and side effects.
• Analysis of pharmacokinetic studies detailing interactions between macrolides and other medications.
• Comparison of metabolic pathways and interaction profiles of erythromycin, clarithromycin, and azithromycin.

Main Results:

• Macrolides exhibit a generally favorable safety profile with low discontinuation rates.
• Specific macrolides, like erythromycin, are associated with QT(c) prolongation.
• Significant pharmacokinetic interactions are documented between erythromycin/clarithromycin and numerous drugs (e.g., cyclosporin, statins, warfarin) metabolized by P450 enzymes.

Conclusions:

• While generally safe, macrolides carry a risk of QT(c) prolongation and significant drug interactions.
• Azithromycin may offer a safer alternative to erythromycin and clarithromycin in patients on concurrent therapy due to a potentially lower interaction profile.
• Careful consideration of concomitant medications is crucial when prescribing macrolides.